Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. (INXB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INXB · as of Jun 9, 2026
Key Statistics
Explore Inhibrx Biosciences, Inc. Data
inxb stock data · financialsCompetitors & Peers
inxb competitorsINXB
CATB
CBLI
CELU
CRGX
MACKStock Performance
Full HistoryAbout Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. operates as a clinical-stage biopharmaceutical entity, primarily focused on developing advanced biologic treatments for critical, life-threatening medical conditions. Key ass…
what is inhibrx biosciences, inc. · inxb stock overview · inhibrx biosciences, inc. company profile · who is inhibrx biosciences, inc. ceo · inxb NASDAQ · inhibrx biosciences, inc. headquarters · inhibrx biosciences, inc. business segments
About Stock Overview & Key Data
Inhibrx Biosciences, Inc. (INXB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 24, 2018. As of the latest trading session, INXB stock price is $15.86, with a market capitalization of $225.9M. The stock has returned +13.94% over the past 12 months and +13.94% year-to-date.
Frequently Asked Questions
As of the latest trading session, Inhibrx Biosciences, Inc. (INXB) stock price is $15.86. The stock is traded on NASDAQ under the ticker symbol INXB. The 52-week range is $12.95 – $18.95.